Ambassador of Kazakhstan discussed the possibility of expanding cooperation with the largest pharmaceutical concern in the Baltics

Riga, October 1, 2024 – Ambassador of Kazakhstan to Latvia Dauren Karipov met with the Chairman of the Board of the Grindex concern, Doctor of Chemical Sciences Juris Hmelnickis.

During the meeting, J. Hmelnickis informed about the current cooperation of the Concern with Kazakhstani pharmaceutical companies aimed at expanding the presence of Grindex in the Kazakhstani market.

In turn, D. Karipov confirmed the interest of the Kazakhstani side in the further participation of the Latvian concern in the development of the pharmaceutical industry of Kazakhstan, including the possibility of localizing production.

 

Reference: Grindex is a leading manufacturer of pharmaceutical products in the Baltic countries, founded in 1946. The Concern's portfolio includes original drugs, generics, as well as active pharmaceutical ingredients produced in accordance with international safety and quality standards. The concern's products are presented in 100 countries worldwide.